Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer
Oncology (Karger), 09/10/09
Chu E et al. – Adjuvant capecitabine monotherapy was associated with lower total medical and chemotherapy–related costs than 5–FU. Reduced complications and costs associated with capecitabine administration offset the higher acquisition cost.
Related Articles
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: An open-label, randomised controlled trial
The Lancet Oncology - Online First, 11/11/09
Relevance Score: 94%
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09
Relevance Score: 89%
North Central Cancer Treatment Group (NCCTG) N0432: Phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Annals of Oncology, 11/16/09
Relevance Score: 87%
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09
Relevance Score: 85%
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Annals of Oncology, 11/16/09
Relevance Score: 85%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer
Case Reports in Gastroenterology, 11/25/09
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09
KRAS Mutational Status as a Predictor of Epidermal Growth Factor Receptor Inhibitor Efficacy in Colorectal Cancer
American Journal of Therapeutics, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer
Case Reports in Gastroenterology, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan
Journal of General Internal Medicine, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


